This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Novartis Ag. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Frank Stephen Kalthoff: Innovator in Pharmaceutical Chemistry
Introduction
Frank Stephen Kalthoff is a notable inventor based in Guntramsdorf, Austria. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific biological pathways.
Latest Patents
Kalthoff holds a patent for "Oxazolidin-2-one-pyrimidine derivatives and the use thereof as phosphatidylinositol-3-kinase inhibitors." This invention relates to oxazolidin-2-one substituted pyrimidine compounds that act as inhibitors of phosphatidylinositol-3-kinase (PI3K). The patent outlines pharmaceutical compositions, methods for their manufacture, and their applications in treating conditions, diseases, and disorders that depend on PI3K.
Career Highlights
Kalthoff is associated with Novartis AG, a leading global healthcare company. His work focuses on innovative solutions in drug development, contributing to advancements in therapeutic options for various medical conditions.
Collaborations
He has collaborated with notable colleagues such as Robin Alec Fairhurst and Pascal Furet, enhancing the research and development efforts within his field.
Conclusion
Frank Stephen Kalthoff's contributions to pharmaceutical chemistry and his innovative patent work exemplify the impact of dedicated inventors in advancing medical science. His ongoing efforts continue to pave the way for new therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile